A

Swiss trademark · 505650 · Combined mark · In force

The mark A as registered

Register entry

Registration number
505650
Application number
08522/2002
Status
In force
Type
Combined mark
As registered
A ((fig.))
Filed
Oct 1, 2002
Registered
Dec 5, 2002
Published
Dec 19, 2002
Protected until
Oct 1, 2032
Language of procedure
German
Vienna classes
07.11.10, 27.05.01, 27.05.08
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung und Vorbeugung von Krankheiten und Störungen des Zentralnervensystems.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 19, 2024

    Publication

    Published in Swissreg on 19.11.2024

  2. Sep 1, 2022

    Renewed

    Published in Swissreg on 01.09.2022

  3. Aug 30, 2022

    Agent removed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)

    Published in Swissreg on 30.08.2022

  4. Aug 30, 2022

    Agent entered

    Representative
    RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 30.08.2022

  5. Jul 4, 2012

    Renewed

    Published in Swissreg on 04.07.2012

  6. Apr 10, 2007

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York (NY 10154), USA → Otsuka Pharmaceutical Co., Ltd., 2-9 Kanda Tsukasa-cho,, Chiyoda-ku, Tokyo 101-8535, Japan
    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 68 of 10.04.2007

  7. Dec 22, 2003

    Partly deleted

    LGS
    5, Pharmazeutische Präparate für die Behandlung und Vorbeugung von Herz- und Gefässkrankheiten, Krankheiten und Störungen des Zentralnervensystems, Schlaganfall, Krebs, Entzündungs- und entzündlichen Krankheiten, Atmungs- und Infektionskrankheiten, Autoimmunkrankheiten, Antibiotika. → 5, Pharmazeutische Präparate für die Behandlung und Vorbeugung von Krankheiten und Störungen des Zentralnervensystems.
    International classification
    5 → 5

    Published in the SOGC no. 246 of 22.12.2003

  8. Dec 19, 2002

    Registered

    Published in the SOGC no. 246 of 19.12.2002

Parties

Holder

Otsuka Pharmaceutical Co., Ltd.

2-9 Kanda Tsukasa-cho, Chiyoda-ku, Tokyo 101-8535, JP

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.